Acadia Healthcare (ACHC)
(Delayed Data from NSDQ)
$70.16 USD
-0.12 (-0.17%)
Updated Apr 19, 2024 04:00 PM ET
After-Market: $70.18 +0.02 (0.03%) 5:18 PM ET
3-Hold of 5 3
C Value B Growth C Momentum B VGM
Balance Sheet
Fiscal Year End for Acadia Healthcare Company, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 100 | 98 | 134 | 379 | 124 |
Receivables | 361 | 322 | 281 | 274 | 340 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 134 | 86 | 80 | 1,871 | 78 |
Total Current Assets | 596 | 506 | 495 | 2,523 | 542 |
Net Property & Equipment | 2,267 | 1,952 | 1,771 | 1,623 | 3,224 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 7 | 3 | 3 | 3 | 3 |
Intangibles | 2,299 | 2,299 | 2,270 | 2,174 | 2,539 |
Deposits & Other Assets | 73 | 93 | 95 | 79 | 68 |
Total Assets | 5,359 | 4,988 | 4,768 | 6,499 | 6,879 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 156 | 105 | 99 | 88 | 127 |
Current Portion Long-Term Debt | 29 | 21 | 19 | 153 | 44 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 674 | 236 | 264 | 303 | 264 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 745 | 0 |
Total Current Liabilities | 886 | 388 | 405 | 1,308 | 464 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 2 | 93 | 74 | 50 | 72 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 1,343 | 1,365 | 1,479 | 2,969 | 3,105 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 140 | 125 | 111 | 133 | 198 |
Minority Interest (Liabilities) | 106 | 88 | 65 | 55 | 33 |
Total Liabilities | 2,577 | 2,175 | 2,251 | 4,600 | 4,374 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 1 | 1 | 1 | 1 | 1 |
Capital Surplus | 2,649 | 2,658 | 2,636 | 2,580 | 2,558 |
Retained Earnings | 132 | 153 | -120 | -310 | 362 |
Other Equity | 0 | 0 | 0 | -371 | -415 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 2,782 | 2,813 | 2,517 | 1,899 | 2,505 |
Total Liabilities & Shareholder's Equity | 5,359 | 4,988 | 4,768 | 6,499 | 6,879 |
Total Common Equity | 2,782 | 2,813 | 2,517 | 1,899 | 2,505 |
Shares Outstanding | 92.20 | 90.90 | 89.90 | 88.90 | 88.50 |
Book Value Per Share | 30.17 | 30.94 | 28.00 | 21.37 | 28.31 |
Fiscal Year End for Acadia Healthcare Company, Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 100 | 100 | 112 | 64 |
Receivables | NA | 361 | 363 | 346 | 346 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 0 | 0 | 0 | 0 |
Other Current Assets | NA | 134 | 241 | 121 | 128 |
Total Current Assets | NA | 596 | 703 | 579 | 538 |
Net Property & Equipment | NA | 2,267 | 2,146 | 2,074 | 1,998 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 7 | 3 | 3 | 3 |
Intangibles | NA | 2,299 | 2,300 | 2,294 | 2,299 |
Deposits & Other Assets | NA | 73 | 72 | 73 | 73 |
Total Assets | NA | 5,359 | 5,346 | 5,150 | 5,044 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 156 | 150 | 149 | 126 |
Current Portion Long-Term Debt | NA | 29 | 27 | 24 | 21 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 674 | 662 | 233 | 205 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 0 | 0 | 0 | 0 |
Total Current Liabilities | NA | 886 | 865 | 432 | 378 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 2 | 70 | 93 | 93 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 1,343 | 1,350 | 1,372 | 1,400 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 146 | 130 | 129 | |
Minority Interest (Liabilities) | NA | 106 | 98 | 91 | 90 |
Total Liabilities | NA | 2,577 | 2,634 | 2,229 | 2,205 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 1 | 1 | 1 | 1 |
Capital Surplus | NA | 2,649 | 2,638 | 2,628 | 2,619 |
Retained Earnings | NA | 132 | 74 | 292 | 219 |
Other Equity | NA | 0 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 2,782 | 2,713 | 2,921 | 2,840 |
Total Liabilities & Shareholder's Equity | NA | 5,359 | 5,346 | 5,150 | 5,044 |
Total Common Equity | 0 | 2,782 | 2,713 | 2,921 | 2,840 |
Shares Outstanding | 92.20 | 92.20 | 92.10 | 92.10 | 92.00 |
Book Value Per Share | 0.00 | 30.17 | 29.45 | 31.72 | 30.87 |